Vijayanarayanan Mahadevan & Deepak Rameshchandra Shah Join Bliss GVS Pharma As Independent Directors

Vijayanarayanan Mahadevan and Deepak Rameshchandra Shah have been appointed as Non-Executive Independent Directors (Additional Directors) of Bliss GVS Pharma Limited, w.e.f. April 3, 2026.

Mahadevan is a Chartered Accountant and finance leader with over 35 years of experience across multiple organisations and geographies, including Alcon, Sandoz, Novartis, and SHV Energy. He has led the establishment of finance functions for new businesses across manufacturing, trading, and research and development environments, with a focus on financial planning and project execution. He has also received recognition at regional and global levels, with his teams acknowledged across APAC and international platforms for performance and leadership.

Shah has contributed to professional publications and serves as an Independent Director on the Boards of The Ruby Mills Ltd., Marathon Nextgen Realty Ltd., and Siyaram Silk Mills Ltd. He is a Fellow Member of the Institute of Chartered Accountants of India (ICAI) with over 36 years of experience in taxation and audit, and is based in Mumbai. He has held leadership roles, including President of the Bombay Chartered Accountants Society and Chairman of the Western Zone of the All India Federation of Tax Practitioners. He currently serves as Chairman of the Direct Taxation Committee of BCAS.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: